SETDB1 and bladder transitional cell carcinoma: The results showed that SETDB1 expression was significantly associated with immune subtypes in BLCA, COAD, KICH, KIRC, LIHC, LUAD, LUSC, ovarian serous cystadenocarcinoma (OV), SARC, STAD, and TGCT (Figure 10(a)).